'BioNTech Scare Evidence Has All Been Dumped'

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2021-03-26 HKT 12:54

Share this story

facebook

  • The government suspended use of the BioNTech jabs on Wednesday. Image: Shutterstock

    The government suspended use of the BioNTech jabs on Wednesday. Image: Shutterstock

A co-chairman of the Medical Association's advisory committee on communicable diseases says he can't understand why the authorities threw away shots of BioNTech's coronavirus vaccine that had defective packaging, saying this must have hampered an investigation into the suspected problem.

The Hong Kong government suspended use of the jabs on Wednesday, saying that on 57 occasions, frontline vaccination workers had reported problems, including cracks in containers, loose caps, and stains or marks on the outside of bottles.

The Director of Health, Constance Chan, said the problematic doses had been dumped.

She also announced that mainland company Fosun, which distributes the BioNTech vaccine in the Greater China region, would be carrying out an immediate investigation, including a review of the whole logistics chain.

But on RTHK's Backchat programme on Friday morning, Dr Alvin Chan warned that the "evidence" appears to have been destroyed.

"I am quite surprised that the Hong Kong authorities said that they had already discarded all the problematic bottles, or the vials of vaccine, when they were detected to be faulty. That means we don't have those bottles as evidence for the company of BioNTech to check what had happened," he said.

"To investigate the problem, at least these faulty bottles need to be examined meticulously by the company ... to really solve the conundrum."

The doctor added that he was happy to hear that at least the suspect doses were not given to members of the public.

Despite the suspension, the government and BioNTech have both said that don't believe there is any safety issue involving the batch of vaccines in question. More than 150,000 Hongkongers have received shots from this batch.

“At this point, we have no reason to believe there is any safety risk posed to the population,” BioNTech said in a statement on Wednesday.

Speaking on the same radio show on Friday, Dr Henry Yeung a former president of Hong Kong Doctors' Union, agreed that the government was right to suspend the use of BioNTech jabs until an investigation is completed.

"Safety is the most important concern of the government and the medical profession. I think we have to ask the factory to look into the matter from all angles before we can continue the jab again," Yeung said.

"For me, I think both BioNTech and Sinovac are pretty safe for use ... I'm going to receive the second jab of the Sinovac today. I have full trust in those two vaccines."

RECENT NEWS

StartmeupHK Festival And Hong Kong Fintech Week 2025 Merge For 10th Anniversary Milestone

Invest Hong Kong (InvestHK) announced on 10 March 2025 that both of its flagship events, Hong Kong Fintech Week 2025 an... Read more

Ant AI-Powered Health Insurance Processes 7.25M Claims In 2024, 55%YoY Increase

In 2024, Ant Insurance, the online insurance brokerage platform of Ant Group, processed 7.25 million health claims, mar... Read more

Ping An Talent Uses AI For Job Matching, But Can Technology Make Recruitment Fairer?

Ping An Insurance (Group) Company of China, Ltd. has launched its 2025 Spring Campus Recruitment, offering over 2,000 p... Read more

HKEX Partners With CMU OmniClear To Boost Post-Trade Securities Infrastructure

Hong Kong Exchanges and Clearing Limited (HKEX) announced on 4 March 2025 that it signed a Memorandum of Understanding ... Read more

PAObank Secures Insurance Agency Licence, Partners With Ping An And FWD Hong Kong

PAO Bank Limited (PAObank) has received its Insurance Agency Licence from the Insurance Authority and signed strategic ... Read more

IFAST Launches Self-Service Accounts For Hong Kong Family Offices

Fintech solutions provider iFAST HK launches self-service accounts in Hong Kong, catering to the growing demand for ind... Read more